Abstract
Amniotic fluid stem cells (AFSC), a unique multipotent stem cell population, have demonstrated significant experimental promise for the treatment of lung injury and disease as well as for de novo tissue engineering. Furthermore, the translation of experimental models, to clinical endpoints in the lung, present a litany of distinct challenges that AFSC have demonstrated the potential to address. With a minimum of 40 phenotypically distinct cell populations, limited regenerative capacity, 23 architecturally and physiologically diverse functional regions and the etiology of many lung diseases and disorders poorly understood, the respiratory system itself is perhaps one of the most challenging systems to treat. This chapter examines some of the challenges posed by the respiratory system, AFSC-based therapy for the treatment lung disease, and the future prospects of this stem cell population within the context of the lung.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Warburton D, El-Hashash A, Carraro G, Tiozzo C, Sala F, Rogers O, De Langhe S, Kemp PJ, Riccardi D, Torday J, Bellusci S, Shi W, Lubkin SR, Jesudason E. Lung organogenesis. Curr Top Dev Biol. 2010;90:73–158.
Shi W, Bellusci S, Warburton D. Lung development and adult lung diseases. Chest. 2007;132:651–6.
Sweet DG, Halliday HL. Modeling and remodeling of the lung in neonatal chronic lung disease: implications for therapy. Treat Respir Med. 2005;4:347–59.
Warrell DA, Cox TM, Firth JD, Weatherall D, Benz EJ. Oxford textbook of medicine. New York: Oxford University Press; 2003.
Blaisdell CJ, Gail DB, Nabel EG. National heart, lung, and blood institute perspective: lung progenitor and stem cells—gaps in knowledge and future opportunities. Stem Cells. 2009;27:2263–70.
Liu X, Engelhardt JF. The glandular stem/progenitor cell niche in airway development and repair. Proc Am Thorac Soc. 2008;5:682–8.
Garcia O, Carraro G, Navarro S, Bertoncello I, McQualter J, Driscoll B, Jesudason E, Warburton D. Cell-based therapies for lung disease. Br Med Bull. 2012;101:147–61.
Sen N, Weprin S, Peter Y. Discrimination between lung homeostatic and injury-induced epithelial progenitor subsets by cell-density properties. Stem Cells Dev. 2013;22:2036–46.
Hegab AE, Nickerson DW, Ha VL, Darmawan DO, Gomperts BN. Repair and regeneration of tracheal surface epithelium and submucosal glands in a mouse model of hypoxic-ischemic injury. Respirology. 2012;17:1101–13.
Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR. In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations. Am J Physiol Lung Cell Mol Physiol. 2004;286:L643–9.
Reynolds SD, Giangreco A, Power JH, Stripp BR. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol. 2000;156:269–78.
Hong KU, Reynolds SD, Giangreco A, Hurley CM, Stripp BR. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol. 2001;24:671–81.
Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol. 2002;161:173–82.
Driscoll B, Kikuchi A, Lau AN, Lee J, Reddy R, Jesudason E, Kim CF, Warburton D. Isolation and characterization of distal lung progenitor cells. Methods Mol Biol. 2012;879:109–22.
Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, Stripp BR, Randell SH, Noble PW, Hogan BLM. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. 2013;123:3025–36.
Rawlins EL, Hogan BL. Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol. 2008;295:L231–4.
Bowden DH. Cell turnover in the lung. Am Rev Respir Dis. 1983;128:S46–8.
Rakower J, Balchum OJ, Dressler SH. Pulmonary and circulatory function of the reexpanded pneumothorax lung. Chest. 1956;30: 649–58.
Ueda K, Tanaka T, Hayashi M, Li TS, Kaneoka T, Tanaka N, Hamano K. Compensation of pulmonary function after upper lobectomy versus lower lobectomy. J Thorac Cardiovasc Surg. 2011;142:762–7.
Weiss DJ, Bates JH, Gilbert T, Liles WC, Lutzko C, Rajagopal J, Prockop DJ. Conference report: stem cells and cell therapies in lung biology and diseases University of Vermont, July 2011. Ann Am Thorac Soc. 2013;10:S25–44.
Weiss DJ. Stem cells, cell therapies and bioengineering in lung biology and diseases: comprehensive review of the recent literature 2010–2012. Ann Am Thorac Soc. 2013;10(5):S45–97.
Kajstura J, Rota M, Hall SR, Hosoda T, D'Amario D, Sanada F, Zheng H, Ogorek B, Rondon-Clavo C, Ferreira-Martins J, Matsuda A, Arranto C, Goichberg P, Giordano G, Haley KJ, Bardelli S, Rayatzadeh H, Liu X, Quaini F, Liao R, Leri A, Perrella MA, Loscalzo J, Anversa P. Evidence for human lung stem cells. N Engl J Med. 2011;364:1795–806.
Hegab AE, Kubo H, Fujino N, Suzuki T, He M, Kato H, Yamaya M. Isolation and characterization of murine multipotent lung stem cells. Stem Cells Dev. 2010;19:523–36.
Buckley S, Shi W, Carraro G, Sedrakyan S, Sacco SD, Driscoll B, Perin L, Filippo RD, Warburton D. The milieu of damaged alveolar epithelial type 2 cells stimulates alveolar wound repair by endogenous and exogenous progenitors. Am J Respir Cell Mol Biol. 2011;45:1212–21.
Garcia O, Carraro G, Turcatel G, Hall M, Sedrakyan S, Roche T, Buckley S, Driscoll B, Perin L, Warburton D. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via ccl2 modulation in bronchoalveolar lavage. PLoS One. 2013;8(8):e71679.
Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J, Turcatel G, Langhe SPD, Driscoll B, Bellusci S, Minoo P, Atala A, Filippo RED, Warburton D. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells. 2008;26:2902–11.
Perin L, Sedrakyan S, Da Sacco S, De Filippo R. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol. 2008;86:85–99.
Perin L, Sedrakyan S, Giuliani S, Sacco SD, Carraro G, Shiri L, Lemley KV, Rosol M, Wu S, Atala A, Warburton D, Filippo RED. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One. 2010;5:e9357.
Sedrakyan S, Sacco SD, Milanesi A, Shiri L, Petrosyan A, Varimezova R, Warburton D, Lemley KV, Filippo RED, Perin L. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol. 2012;23:661–73.
Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, Nowakowska B, Phoolchund A, Lay K, Ramasamy TS, Cananzi M, Nettersheim D, Sullivan M, Frost J, Moore G, Vermeesch JR, Fisk NM, Thrasher AJ, Atala A, Adjaye J, Schorle H, Coppi PD, Guillot PV. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012;20:1953–67.
Da Sacco S, Sedrakyan S, Boldrin F, Giuliani S, Parnigotto P, Habibian R, Warburton D, De Filippo RE, Perin L. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol. 2010;183:1193–200.
Coppi PD, Bartsch Jr G, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25:100–6.
Siddiqui M, Atala A. Amniotic fluid-derived pluripotent cells, Handbook of stem cells, vol. 2. Burlington: Elsevier; 2004. p. 175–9.
Delo DM, De Coppi P, Bartsch Jr G, Atala A. Amniotic fluid and placental stem cells. Methods Enzymol. 2006;419:426–38.
Pederiva F, Ghionzoli M, Pierro A, De Coppi P, Tovar JA. Amniotic fluid stem cells rescue both in vitro and in vivo growth, innervation and motility in nitrofen-exposed hypoplastic rat lungs through paracrine effects. Cell Transplant. 2013;22(9):1683–94.
Grisafi D, Pozzobon M, Dedja A, Vanzo V, Tomanin R, Porzionato A, Macchi V, Salmaso R, Scarpa M, Cozzi E, Fassina A, Navaglia F, Maran C, Onisto M, Caenazzo L, De Coppi P, De Caro R, Chiandetti L, Zaramella P. Human amniotic fluid stem cells protect rat lungs exposed to moderate hyperoxia. Pediatr Pulmonol. 2013;48(11):1070–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Garcia, O., Warburton, D. (2014). Amniotic Fluid Stem Cell Therapy for Lung Disease. In: Atala, A., Murphy, S. (eds) Perinatal Stem Cells. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1118-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1118-9_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1117-2
Online ISBN: 978-1-4939-1118-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)